Managing pain without resorting to surgery is called non-invasive pain management. As the global cancer rate rises and the number of reported trauma cases rises, so does the need for effective pain management. According to data from the CDC published in 2014, trauma is responsible for 41 million annual visits to the hospital emergency room in the United States. There are three main types of pain management: those that involve the use of drugs, those that don’t, and those that involve surgery. Specific exercises, manual methods involving force techniques to the affected area, behavioral adaptation which include cognitive therapy, superficial heating and cooling of the skin, and the use of electrotherapy devices all belong to the noninvasive, nondrug pain management process.
Request a Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/106
The United States, the United Kingdom, and Germany, along with other developed economies, have a high adoption rate because of the superior healthcare infrastructure and widespread accessibility in these locations. Every year, over 100 Mn people in the United States experience chronic pain, 25.8 Mn experience diabetes, 16.3 Mn experience coronary heart disease, and 11.9% experience cancer, according to a report by the American academy of pain medicine. It is anticipated that this figure will rise even higher in the not-too-distant future. The global market for noninvasive pain management devices is predicted to expand in response to the ageing population, the rising incidence of spinal cord injuries and MS, and the rising number of trauma cases. Government and non-government organizations like the National Institutes of Health (NIH) are investing more money into programs like Brain Research through Advancing Innovative Neurotechnologies (BRAIN) to learn more about the brain and use that knowledge for therapeutic purposes, such as more efficient pain management. Through this program neurologists and other scientists are encouraged to work together to speed up the creation and implementation of various technologies. The national pain strategy was released in March 2016 by the office of the assistant secretary for health at the United States Department of Health and Human Services. This strategy includes benefits for people suffering from chronic pain, and is expected to be responsible for a decrease in the prevalence of pain in the pediatric and geriatric populations.
Increasing emphasis on growth of drug-free treatment options
In order to set themselves apart from rivals, businesses are concentrating on bringing to market cutting-edge devices with unique capabilities. In July of 2016, Bayer introduced a professional grade TENS device called Aleve Direct Therapy TENS Device. The tool is employed to temporarily alleviate the discomfort caused by muscle fatigue and soreness. In 2015, the World Health Organization estimated that 20% of the adult people living in Europe suffered from chronic pain, and that 16% of the population in the U.S. experienced ongoing and severe pain. This is expected to drive significant growth in the non-invasive pain management devices market. Increased government initiatives, such as Australia’s in 2005 following the approval of the multidisciplinary faculty of pain medicine, to improve pain management facilities in the country for cancer patients, are anticipated to drive growth of the global non-invasive pain management market.
Extremely dispersed industry, with plenty of room for expansion.
Due to the presence of both well-established and up-and-coming competitors, the global market for non-invasive pain management devices is extremely fragmented. Companies are leaning towards developing user-friendly apps for identifying chronic pain symptoms. To give just one indication, Pfizer Inc. is putting in considerable time and energy into developing a mobile app for detecting chronic pain; a version of this app is scheduled for release in 2017. Further, Iskra Medical d.o.o, ActivLife Technologies Pty Ltd, Chattanooga International, Zynex Medical, I-Tech Medical Division, and MediHighTec are all significant players in the non-invasive pain management devices market.
Limited Period Offer | Report Available Now at UP TO 45% off Discounted Pricing @
Single User License : https://www.coherentmarketinsights.com/promo/buynow/106
Multi Users License : https://www.coherentmarketinsights.com/promo/buynow/106
Corporate Users License : https://www.coherentmarketinsights.com/promo/buynow/106
The United States, the United Kingdom, and Germany, along with other developed economies, have a high adoption rate because of the superior healthcare infrastructure and widespread accessibility in these locations. Every year, over 100 Mn people in the United States experience chronic pain, 25.8 Mn experience diabetes, 16.3 Mn experience coronary heart disease, and 11.9% experience cancer, according to a report by the American academy of pain medicine. It is anticipated that this figure will rise even higher in the not-too-distant future. The global market for noninvasive pain management devices is predicted to expand in response to the ageing population, the rising incidence of spinal cord injuries and MS, and the rising number of trauma cases. Government and non-government organizations like the National Institutes of Health (NIH) are investing more money into programs like Brain Research through Advancing Innovative Neurotechnologies (BRAIN) to learn more about the brain and use that knowledge for therapeutic purposes, such as more efficient pain management. Through this program neurologists and other scientists are encouraged to work together to speed up the creation and implementation of various technologies. The national pain strategy was released in March 2016 by the office of the assistant secretary for health at the United States Department of Health and Human Services. This strategy includes benefits for people suffering from chronic pain, and is expected to be responsible for a decrease in the prevalence of pain in the pediatric and geriatric populations.
Increasing emphasis on growth of drug-free treatment options
In order to set themselves apart from rivals, businesses are concentrating on bringing to market cutting-edge devices with unique capabilities. In July of 2016, Bayer introduced a professional grade TENS device called Aleve Direct Therapy TENS Device. The tool is employed to temporarily alleviate the discomfort caused by muscle fatigue and soreness. In 2015, the World Health Organization estimated that 20% of the adult people living in Europe suffered from chronic pain, and that 16% of the population in the U.S. experienced ongoing and severe pain. This is expected to drive significant growth in the non-invasive pain management devices market. Increased government initiatives, such as Australia’s in 2005 following the approval of the multidisciplinary faculty of pain medicine, to improve pain management facilities in the country for cancer patients, are anticipated to drive growth of the global non-invasive pain management market.
Extremely dispersed industry, with plenty of room for expansion.
Due to the presence of both well-established and up-and-coming competitors, the global market for non-invasive pain management devices is extremely fragmented. Companies are leaning towards developing user-friendly apps for identifying chronic pain symptoms. To give just one indication, Pfizer Inc. is putting in considerable time and energy into developing a mobile app for detecting chronic pain; a version of this app is scheduled for release in 2017. Further, Iskra Medical d.o.o, ActivLife Technologies Pty Ltd, Chattanooga International, Zynex Medical, I-Tech Medical Division, and MediHighTec are all significant players in the non-invasive pain management devices market.
The market for NPMD (non-invasive pain management devices) worldwide is categorized on the basis of following divisions.
- Product Type:
- Electrical Stimulation Devices
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- Trigeminal Nerve Stimulation (TNS)
- Neuromuscular Electrical Stimulation (NMES/EMS) Devices
- Transcranial magnetic stimulation (TMS)
- Combination Devices
- Others
- Application Type:
- Neuropathic Pain
- Facial & Migraine Pain
- Cancer Pain
- Trauma
- Musculoskeletal Pain
- End Users:
- Hospitals
- Long-term care centers
- Ambulatory Surgical Centers
- Specialized Clinics
- Others
As contrasting to relying on drugs or surgery, non-invasive pain management looks at the patient as a whole, seeks out permanent fixes to address the underlying causes of the pain, and encourages the body’s natural ability to heal itself.
Major market for NPMD (Non-invasive pain management devices): Orbasone Pain Relief System (Orthometrix, Inc), Medio UniSono eco (Iskra Medical), Medio MULTI eco (Iskra Medical), ActivBody, Apostherapy (Sportsmed), VitalStim Plus (DJO Global) etc.
Request For Customization at: https://www.coherentmarketinsights.com/insight/request-customization/106
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Non-invasive Pain Management Devices Market Size Analysis from 2023 to 2030
11.6 COVID-19 Outbreak: Non-invasive Pain Management Devices Industry Impact
Chapter 2 Global Non-invasive Pain Management Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Non-invasive Pain Management Devices (Volume and Value) by Type
2.3 Global Non-invasive Pain Management Devices (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Non-invasive Pain Management Devices Sales, Consumption, Export, Import by Regions (2017-2030)
Chapter 5 North America Non-invasive Pain Management Devices Market Analysis
Chapter 6 East Asia Non-invasive Pain Management Devices Market Analysis
Chapter 7 Europe Non-invasive Pain Management Devices Market Analysis
Chapter 8 South Asia Non-invasive Pain Management Devices Market Analysis
Chapter 9 Southeast Asia Non-invasive Pain Management Devices Market Analysis
Chapter 10 Middle East Non-invasive Pain Management Devices Market Analysis
Chapter 11 Africa Non-invasive Pain Management Devices Market Analysis
Chapter 12 Oceania Non-invasive Pain Management Devices Market Analysis
Chapter 13 South America Non-invasive Pain Management Devices Market Analysis
Chapter 14 Company Profiles and Key Figures in Non-invasive Pain Management Devices Business
Chapter 15 Global Non-invasive Pain Management Devices Market Forecast (2023-2030)
Chapter 16 Conclusions
Research Methodology
About Us:
Coherent Market Insights is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Coherent Market Insights has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Coherent are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.
Contact Us :
Mr. Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States.
U.S.A: +1-206-701-6702
UK: +44-020-8133-4027
JAPAN: +050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com/